Aisling M. Ross
Impact in
-
- Nanoparticle-Based Drug Delivery
-
- Advanced Drug Delivery Systems
Papers in
-
- Ubiquitin and proteasome pathways 1
- Oncology 4
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- John J. Mulvihill (9 shared papers)Andreas M. Grabrucker (5 shared papers)Eoghan M. Cunnane (1 shared paper)Giovanni Tosi (1 shared paper)Jason Thomas Duskey (1 shared paper)David Newport (2 shared papers)Kieran McGourty (2 shared papers)Lynnette Marcar (2 shared papers)
- Journals
- Acta Biomaterialia (2 papers)Pharmaceutics (1 paper)Life (1 paper)Nutrition Metabolism and Cardiovascular Diseases (1 paper)Materials Science and Engineering C (1 paper)
- Partner nations
- IrelandUnited KingdomItaly
In The Last Decade
Aisling M. Ross
13 papers receiving 282 citations
Peers
Comparison fields: 5 of 71
- Biomaterials 61
- Pharmaceutical Science 26
- Neurology 27
- Neurology 29
- Biological Psychiatry 4
Countries citing papers authored by Aisling M. Ross
This map shows the geographic impact of Aisling M. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisling M. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisling M. Ross more than expected).
Fields of papers citing papers by Aisling M. Ross
This network shows the impact of papers produced by Aisling M. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisling M. Ross. The network helps show where Aisling M. Ross may publish in the future.
Co-authors
The 25 scholars most cited alongside Aisling M. Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 118 | |
| 2 | 2018 | 30 | |
| 3 | 2024 | 29 | |
| 4 | 2021 | 26 | |
| 5 | 2023 | 15 | |
| 6 | 2019 | 14 | |
| 7 | 2023 | 13 | |
| 8 | 2020 | 11 | |
| 9 | 2021 | 11 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 2 | |
| 13 | 2024 | 1 |
About Aisling M. Ross
Aisling M. Ross is a scholar working on Molecular Biology, Oncology, Biomaterials, Materials Chemistry and Neurology, having authored 13 papers that have together received 285 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (4 papers), Nanoparticles: synthesis and applications (3 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Barrier Structure and Function Studies (2 papers), Automotive and Human Injury Biomechanics (2 papers), Vitamin K Research Studies (1 paper) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Biomaterials (61 citations), Pharmaceutical Science (26 citations), Neurology (27 citations), Neurology (29 citations) and Biological Psychiatry (4 citations). Aisling M. Ross has collaborated with scholars based in Ireland, United Kingdom and Italy. Frequent co-authors include John J. Mulvihill, Andreas M. Grabrucker, Eoghan M. Cunnane, Giovanni Tosi, Jason Thomas Duskey, David Newport, Kieran McGourty, Lynnette Marcar, Conor Fearon and Zhou Zhou. Their work appears in journals such as Acta Biomaterialia, Pharmaceutics, Life, Nutrition Metabolism and Cardiovascular Diseases and Materials Science and Engineering C.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.